Over the past two decades, there has been a significant increase in the incidence of primary liver cancer in the USA, with higher rates observed in men.
Roivant CEO hints at more deals shaping up as key Immunovant data loom
Roivant Sciences has more potential asset deals in the works — after setting up two Vants around Pfizer assets in the past two years —